Hyperprogression with immunotherapy: Is it real?

被引：17
|
作者：
Popat, Sanjay [1 ,2 ,3 ]
机构：
[1] Royal Marsden Hosp, Dept Med, 203 Fulham Rd, London SW3 6JJ, England
[2] Imperial Coll London, Natl Heart & Lung Inst, Genom Med, London, England
[3] Inst Canc Res, Thorac Oncol, London, England
来源：
CANCER | 2019年 / 125卷 / 08期
关键词：
D O I：
10.1002/cncr.31997
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1218 / 1220
页数：3
相关论文
共 50 条
  • [31] Redefining Clinical Hyperprogression: The Incidence, Clinical Implications, and Risk Factors of Hyperprogression in Non-Small Cell Lung Cancer Treated with Immunotherapy
    Djunadi, Trie Arni
    Oh, Youjin
    Lee, Jeeyeon
    Yu, Jisang
    Chung, Liam Il-Young
    Lee, Yeunho
    Kim, Leeseul
    Hong, Timothy
    Lee, Soowon
    Shah, Zunairah
    Park, Joo Hee
    Yoon, Sung Mi
    Chae, Young Kwang
    [J]. CLINICAL LUNG CANCER, 2024, 25 (04)
  • [32] SAA1 and metabolomic signatures predict hyperprogression with immunotherapy in pan cancers
    Wang, Xiaoqing
    Zhang, Longshan
    Liao, Liwei
    Li, Nan
    Tang, Tingxi
    Sun, Jianda
    Zhou, Zhenhua
    Liu, Yang
    Huang, Jihong
    Wang, Yingqiao
    Chen, Zekai
    Zhang, Hanbin
    Xiao, Ting
    Tian, Yunming
    Zheng, Xiuting
    Yuan, Yi
    Xiao, Linlin
    Liu, Laiyu
    Guan, Jian
    [J]. CLINICAL AND TRANSLATIONAL MEDICINE, 2024, 14 (03):
  • [33] Hyperprogression-Immunotherapy-Related Phenomenon vs Intrinsic Natural History of Cancer
    Pearson, Alexander T.
    Sweis, Randy F.
    [J]. JAMA ONCOLOGY, 2019, 5 (05) : 743 - 743
  • [34] Clinical and Genetic Characterization of Hyperprogression Based on Volumetry in Advanced NSCLC Treated with Immunotherapy
    Kim, Y.
    Kim, C. H.
    Lee, S.
    Lee, H. Y.
    Kim, H. S.
    Kim, K.
    Sun, J.
    Ahn, J. S.
    Ahn, M.
    Park, K.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S245 - S245
  • [35] Is there an Association between Lymph Node Size and Hyperprogression in Immunotherapy-Treated Patients?
    Alkader, Mohammad S.
    Altaha, Rashed Z.
    Jabali, Eslam H.
    Attieh, Ola A.
    Matalqa, Ala' W.
    [J]. ROMANIAN JOURNAL OF INTERNAL MEDICINE, 2024, 62 (01) : 33 - 43
  • [36] Characterization of Hispanic Patients Who Experienced Hyperprogression During Treatment for Advanced NSCLC with Immunotherapy
    Arrieta, O.
    Ruiz-Patino, A.
    Cardona, A. F.
    Martin, C.
    Raez, L.
    Zatarain Barron, L.
    Barron, F.
    Ricaurte, L.
    Bravo-Garzon, M. A.
    Mas, L.
    Corrales-Rodriguez, L.
    Rojas, L.
    Lupinacci, L.
    Perazzo, F.
    Bas, C.
    Carranza, O.
    Pupareli, C.
    Rizzo, M.
    Ruiz Mendoza, R.
    Rolfo, C. D.
    Archila, P.
    Rodriguez, J.
    Sotelo, C.
    Vargas, C.
    Carranza, H.
    Otero, J.
    Pino, L. E.
    Ortiz, C.
    Laguado, P.
    Rosell, R.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : S1194 - S1195
  • [37] Hyperprogression-Immunotherapy-Related Phenomenon vs Intrinsic Natural History of Cancer Reply
    Ferrara, Roberto
    Caramella, Caroline
    Besse, Benjamin
    [J]. JAMA ONCOLOGY, 2019, 5 (05) : 744 - 744
  • [38] Hyperprogression After Immunotherapy for Primary Small Cell Neuroendocrine Carcinoma of the Ureter: A Case Report
    Qing, Defeng
    Peng, Luxing
    Cen, Feng
    Huang, Xinjun
    Wei, Qiang
    Lu, Heming
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [39] Characterization of Hispanic Patients Who Experienced Hyperprogression During Treatment for Advanced NSCLC with Immunotherapy
    Arrieta, O. G.
    Ruiz-Patino, A.
    Cardona, A. F.
    Martin, C.
    Raez, L.
    Zatarain Barron, Z. L.
    Barron, F.
    Ricaurte, L.
    Bravo-Garzon, M. A.
    Mas, L.
    Corrales, L.
    Rojas, L. L.
    Lupinacci, L.
    Perazzo, F.
    Bas, C.
    Carranza, O.
    Puparelli, C.
    Rizzo, M.
    Ruiz, R.
    Rolfo, C.
    Archila, P.
    Rodriguez, J.
    Sotelo, C.
    Vargas, C.
    Carranza, H.
    Otero, J.
    Pino, L.
    Ortiz, C.
    Laguado, P.
    Rosell, R.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S474 - S474
  • [40] Hyperprogression and Pseudoprogression in Patients with Non-Small Cell Lung Cancer on Checkpoint Blocking Immunotherapy
    Kim, S.
    Kim, J.
    Hong, S.
    Kang, J.
    Chung, S. H.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S888 - S889
12345